Regal Assets Analytics

Call Us: (800) 891-1526

M - F 8AM to 4PM ET

SanaCurrents

Gritstone, BioXcel Expect to Report Catalysts in July 2020; 2Q SanaCurrents Update

By |2020-07-07T07:48:32-04:00July 6th, 2020|Categories: Bill Langbein, Healthcare, Pharmaceutical & Biotechnology, SanaCurrents, SanaCurrents Updates|

Gritstone Oncology (NASDAQ:GRTS) plans to hold a conference call and [...]

New Magenta Catalyst MGTA-145 After Company Drops MGTA-456 Phase II Trial

By |2020-07-06T10:23:39-04:00June 26th, 2020|Categories: Bill Langbein, SanaCurrents, SanaCurrents Probability Sentiment, SanaCurrents Updates|Tags: |

Shares of Magenta Therapeutics (NASDAQ: MGTA) declined 22% on June [...]

Molecular Templates (MTEM) Probability Sentiment

By |2020-07-06T10:24:03-04:00June 13th, 2020|Categories: Bill Langbein, Healthcare, Pharmaceutical & Biotechnology, SanaCurrents, SanaCurrents Probability Sentiment|

Molecular Templates, Inc. (NASDAQ:MTEM) Probability Sentiment [...]

Selecta Licenses Away Promising Gout Drug; SanaCurrents Suspending Coverage

By |2020-07-06T10:24:12-04:00June 12th, 2020|Categories: Bill Langbein, Healthcare, Pharmaceutical & Biotechnology, SanaCurrents Updates|Tags: , , |

After the market closed on June 11, Selecta Biosciences, Inc. [...]